>That's an explicit fundamentally important ethical issue, but raising it might imperil academic funding from pharmaceutical corporations, so they stick to thei

>That's an explicit fundamentally important ethical issue, but raising it might imperil academic funding from pharmaceutical corporations, so they stick to their safe topics. That's exactly what it is. It's like theatre. No one is consistently talking about that issue, or a host of other issues. The focus is always on a few highly polarized and controversial issues. No one is really interested in breaking character and trying to change the conversation to something of substance. It's easier that way, everything is predictable and controlled.